CapsoVision, Inc Financing Cash Flow
CapsoVision, Inc (CV) reported Financing Cash Flow of $13.51 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-13
- CapsoVision, Inc net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$443.00K, a 137.93% decline year-over-year.
- CapsoVision, Inc net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $13.95M, a 40935.29% increase year-over-year.
- CapsoVision, Inc net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $15.00K, a 99.70% decline year-over-year.
- CapsoVision, Inc net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $22.39M, a 123.85% increase year-over-year.
- CapsoVision, Inc net cash provided by (used in) financing activities for fiscal 2025 was $23.60M, a 56.59% increase from fiscal 2024.
- CapsoVision, Inc net cash provided by (used in) financing activities for fiscal 2024 was $15.07M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$443.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $13.51M 10-Q · filed 2026-08-13 | $13.52M derived: sum of 3 quarters · filed 2026-08-13 | $35.91M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $13.95M 10-Q · filed 2026-05-14 | $13.97M derived: sum of 2 quarters · filed 2026-05-14 | $36.35M derived: sum of 3 quarters · filed 2026-05-14 | $37.52M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $22.40M derived: sum of 2 quarters · filed 2026-03-26 | $23.57M derived: sum of 3 quarters · filed 2026-08-13 | $23.60M 10-K · filed 2026-03-26 |
| 2025-09-30 | $22.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $23.55M derived: sum of 2 quarters · filed 2026-08-13 | $23.59M 10-Q · filed 2025-11-13 | $28.59M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.20M 10-Q · filed 2026-08-13 | $6.20M derived: sum of 3 quarters · filed 2026-08-13 | $16.20M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $34.00K 10-Q · filed 2026-05-14 | $5.04M derived: sum of 2 quarters · filed 2026-05-14 | $15.04M derived: sum of 3 quarters · filed 2026-05-14 | |
| 2024-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $15.00M derived: sum of 2 quarters · filed 2026-03-26 | $15.07M 10-K · filed 2026-03-26 | |
| 2024-09-30 | $10.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $10.07M 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | $72.00K 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B |